60
Participants
Start Date
March 13, 2018
Primary Completion Date
October 17, 2018
Study Completion Date
October 17, 2018
Ketamine Injectable Solution
"Once IV access has been obtained and a facemask has been applied for pre-oxygenation, the loading dose (0.25 mg/kg) of the study drug will be given over 60 seconds and the fixed infusion (5 mcg/kg/min to a maximum of 60 mg/hour) will be initiated by the anesthetist through the pump interface.~The study drug will be infused at a constant rate of 5 mcg/kg/min throughout the maintenance phase, until the end of the procedure (last suture), up to a maximum cumulative dose of 100 mg. If at any point the anesthesiologist feels that it is clinically necessary to reduce the amount of study drug infusion rate, they may opt to reduce the infusion rate by 50% (to 2.5 mcg/kg/min), or stop the infusion entirely."
Placebo
Participants in the control group will receive an equivalent volume bolus and infusion of normal saline to mimic the ketamine infusion in the ketamine group.
Fraser Health: Eagle Ridge Hospital, Port Moody
Lead Sponsor
Collaborators (1)
Fraser Health
OTHER
Office of Naval Research (ONR)
FED
NeuroWave Systems Inc.
INDUSTRY